Early and intensive interventions for children with chromosomal abnormalities or other genetic conditions that may be associated with intellectual disability
SBU does not issue recommendations or guidelines on how healthcare, dental care or social services should operate, or on which interventions and methods should be provided. SBU critically appraises and synthesises research on interventions and methods through systematic reviews.
Question
What are the effects of early and intensive interventions for children with chromosomal abnormalities or other genetic conditions that may be associated with intellectual disability?
PICO
- Population: Children with any of the prespecified chromosomal abnormalities or other genetic conditions that may be associated with intellectual disability, regardless of whether intellectual disability has been established in the child
- Intervention: Non-pharmacological interventions initiated before the age of 7 years and comprising at least 10 intervention sessions within a six-month period
- Comparison: No intervention, waitlist control, or usual care
- Outcome: Outcomes related to participation, activity (execution of a task or action), body functions (e.g., communication abilities and motor function), and adaptive functioning
Method
A systematic literature search was performed using the following databases: Ovid Medline via Ovid, Scopus, and PsycInfo via EBSCO.
Two authors independently assessed the abstracts of all identified studies.
Risk of bias in relevant systematic reviews was assessed using an assessment tool based on AMSTAR.
Identified literature
One relevant systematic reviews with low to moderate risk of bias were identified [1]. The results and conclusions are presented in Table 1. In five relevant systematic reviews, the risk of bias was considered to be high, therefore the results and conclusions are not reported [2-6].
| Included studies | Population, Intervention, Control | Outcome and Results |
|---|---|---|
| O’Toole et al, 2018 [1] Parent-mediated interventions for promoting communication and language development in young children with Down syndrome |
||
| 2 randomized controlled studies 1 quasi-randomized controlled studies Setting: Canada: 1 study Turkey: 1 study USA: 1 study |
Population: Primary caregivers of children with Down syndrome aged between birth and six years Intervention: All parent‐mediated interventions designed to improve communication and language in children with Down syndrome from birth to six years of age Control: Treatment as usual Clinician‐mediated treatment Wait-listed treatment No treatment |
Primary outcomes: Expressive and receptive language and communication Results could not be pooled in a meta-analysis because of differences in outcome measures and reporting. Results from individual studies were inconsistent and the certainty of the evidence was assessed as very low. |
| Authors' conclusion: “Overall, this narrative review is inconclusive as to whether children with Down syndrome make gains in language and communication skills following parent‐mediated intervention.” |
||
References
- O'Toole C, Lee AS, Gibbon FE, van Bysterveldt AK, Hart NJ. Parent-mediated interventions for promoting communication and language development in young children with Down syndrome. Cochrane Database Syst Rev. 2018;10(10):CD012089. Available from: https://doi.org/10.1002/14651858.CD012089.pub2
- Gómez-Cotilla R, López-de-Uralde-Selva MdlÁ, Valero-Aguayo L. Efficacy of Early Intervention Programmes: Systematic Review and Meta-analysis. Psicol Educ (Madr). 2024;30(1):1–10. Available from: https://doi.org/10.5093/psed2024a1
- Kinaci-Biber E, Onerge K, Mutlu A. Gait characteristics and effects of early treadmill intervention in infants and toddlers with down syndrome: a systematic review. Disabil Rehabil. 2022;44(26):8139–48. Available from: https://doi.org/10.1080/09638288.2021.2010818
- Rodriguez-Grande EI, Buitrago-Lopez A, Torres-Narvaez MR, Serrano-Villar Y, Verdugo-Paiva F, Avila C. Therapeutic exercise to improve motor function among children with Down Syndrome aged 0 to 3 years: a systematic literature review and meta‑analysis. Sci Rep. 2022;12(1):13051. Available from: https://doi.org/10.1038/s41598-022-16332-x
- Seager E, Sampson S, Sin J, Pagnamenta E, Stojanovik V. A systematic review of speech, language and communication interventions for children with Down syndrome from 0 to 6 years. Int J Lang Commun Disord. 2022;57(2):441–63. Available from: https://doi.org/10.1111/1460-6984.12699
- Te Kaat‐van den Os DJA, Jongmans MJ, Volman MJM, Lauteslager PEM. Parent‐Implemented Language Interventions for Children with a Developmental Delay: A Systematic Review. J Policy Pract Intellect Disabil. 2017;14(2):129–37. Available from: https://doi.org/10.1111/jppi.12181
Search strategies
Medline via OvidSP 24 June 2026
| / = Term from the MeSH controlled vocabulary; .sh = Term from the MeSH controlled vocabulary; exp = Term from MeSH including terms found below this term in the MeSH hierarchy; .ti,ab = Title or abstract; .tw = Title or abstract; .kf = Keywords; .kw = Keywords, exact; .bt = Book title. NLM Bookshelf; .pt = Publication type; .ja = Journal abbreviation; .af = All fields; adjn = Adjacent. Proximity operator retrieving adjacent words, adj3 retrieves records with search terms within two terms from each other; * or $ = Truncation; “ “ = Citation Marks; searches for an exact phrase | ||
| Search terms | Items found | |
|---|---|---|
| Population: | ||
| 1. | Down Syndrome/ or Fragile X Syndrome/ or Trisomy 13 Syndrome/ or Rett Syndrome/ or Trisomy 18 Syndrome/ or Williams Syndrome/ or Angelman Syndrome/ or Prader-Willi Syndrome/ or Cri-du-Chat Syndrome/ | 44 590 |
| 2. | ("down* syndrome" or (trisomy adj2 "21") or "fragile x syndrome" or "martin-bell syndrome" or "1p36 deletion" or "patau* syndrome" or (trisomy adj2 "13") or "rett* syndrome" or "edward* syndrome" or (trisomy adj2 "18") or "williams syndrom" or "williams-beuren* syndrome" or "angelman* syndrome" or "prader-willi* syndrome" or "dravet* syndrome" or "marker chromosome 15" or "isodicentric 15" or "cri-du-chat syndrome" or "5p deletion syndrome").ab,bt,kf,ti. | 54 373 |
| 3. | exp Child/ or exp Infant/ or Pediatrics/ | 3 032 783 |
| 4. | (child* or kid* or toddler* or boy* or girl* or preshool* or pre-shool* or infant* or newborn* or new-born* or neonat* or baby* or babies or p?ediatric*).ab,bt,kf,ti. | 3 651 856 |
| Study types: systematic reviews and meta-analysis / randomized controlled trials1 | ||
| 5. | (Systematic Review/ or Meta-Analysis/ or Cochrane Database Syst Rev.ja. or (((systematic or realist or integrative or mixed method* or umbrella) adj4 (review)) or "meta analys*" or metaanalys*).ti,bt,ab.) not (editorial/ or letter/ or case reports/) | 628 490 |
| Combined sets: | ||
| 6. | 1 or 2 | 64 826 |
| 7. | 3 or 4 | 4 710 561 |
| 8. | 6 and 7 | 32 520 |
| Final result | ||
| 9. | 8 and 5 | 488 |
1. Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity- and precision-maximizing version (2008 revision); Ovid format. The Cochrane Collaboration; 2008. Available from: https://training.cochrane.org/handbook/current/chapter-04-technical-supplement-searching-and-selecting-studies#section-3-6-1. with modifications: the following terms are added: clinical trial, phase iii.pt. ; randomised.ab. ; ("Phase 3" or "phase3" or "phase III" or P3 or "PIII").ti,ab,kw.
Scopus via scopus.com 24 June 2026
| TITLE-ABS-KEY = Title, abstract or keywords (including indexed keywords and author keywords); ALL = All fields; W/n = Within. Proximity operator retrieving terms within n words from each other; PRE/n = Precedes by. Proximity operator, the first term in the search must precede the second by n words; LIMIT-TO (X) = Includes only results of specified type, e.g., publication type or time range; DOCTYPE = Publication type; “re” = review; “le” = letter; “ed” = editorial; “ch” = book chapter; “cp” = conference proceedings; * = Truncation; “ “ = Citation Marks; searches for an exact phrase | ||
| Search terms | Items found | |
|---|---|---|
| Population: | ||
| 1. | TITLE-ABS-KEY ("down* syndrome" OR ( trisomy W/1 "21") OR "fragile x syndrome" OR "martin-bell syndrome" OR "1p36 deletion" OR "patau* syndrome" OR (trisomy W/1 "13") OR "rett* syndrome" OR "edward* syndrome" OR (trisomy W/1 "18") OR "williams syndrom" OR "williams-beuren* syndrome" OR "angelman* syndrome" OR "prader-willi* syndrome" OR "dravet* syndrome" OR "marker chromosome 15" OR "isodicentric 15" OR "cri-du-chat syndrome" OR "5p deletion syndrome" ) | 92 442 |
| 2. | TITLE-ABS-KEY (child* OR kid* OR toddler* OR boy* OR girl* OR preshool* OR pre-shool* OR kindergarten* OR infant* OR newborn* OR new-born* OR neonat* OR baby* OR babies OR p?ediatric*) | 7 167 880 |
| Study types: systematic reviews and meta-analysis / randomized controlled trials | ||
| 3. | TITLE-ABS-KEY (((systematic OR realist OR integrative OR “mixed method*” or umbrella) W/3 review) OR "meta analy*" OR metaanaly*) AND (EXCLUDE (DOCTYPE, “le”) OR EXCLUDE (DOCTYPE, “ed”) OR EXCLUDE (DOCTYPE, “ch”) OR EXCLUDE (DOCTYPE, “cp”)) | 945 870 |
| Combined sets: | ||
| 4. | 1 and 2 | 47 662 |
| Final result | ||
| 5. | 4 and 3 | 1077 |
PSYCINFO via EBSCO 24 June 2026
| TI = Title; AB = Abstract; SU = Keyword, exact or part (including all other fields for indexed and author keywords); DE = Exact keyword; TX = All text; MR = Methodology; Nn = Near. Proximity operator retrieving terms within n words from each other; * = Truncation; “ “ = Citation Marks; searches for an exact phrase | ||
| Search terms | Items found | |
|---|---|---|
| Population: | ||
| 1. | TI ("down* syndrome" OR (trisomy N1 "21") OR "fragile x syndrome" OR "martin-bell syndrome" OR "1p36 deletion" OR "patau* syndrome" OR (trisomy N1 "13") OR "rett* syndrome" OR "edward* syndrome" OR (trisomy N1 "18") OR "williams syndrom" OR "williams-beuren* syndrome" OR "angelman* syndrome" OR "prader-willi* syndrome" OR "dravet* syndrome" OR "marker chromosome 15" OR "isodicentric 15" OR "cri-du-chat syndrome" OR "5p deletion syndrome") OR AB ("down* syndrome" OR (trisomy N1 "21") OR "fragile x syndrome" OR "martin-bell syndrome" OR "1p36 deletion" OR "patau* syndrome" OR (trisomy N1 "13") OR "rett* syndrome" OR "edward* syndrome" OR (trisomy N1 "18") OR "williams syndrom" OR "williams-beuren* syndrome" OR "angelman* syndrome" OR "prader-willi* syndrome" OR "dravet* syndrome" OR "marker chromosome 15" OR "isodicentric 15" OR "cri-du-chat syndrome" OR "5p deletion syndrome") OR SU ("down* syndrome" OR (trisomy N1 "21") OR "fragile x syndrome" OR "martin-bell syndrome" OR "1p36 deletion" OR "patau* syndrome" OR (trisomy N1 "13") OR "rett* syndrome" OR "edward* syndrome" OR (trisomy N1 "18") OR "williams syndrom" OR "williams-beuren* syndrome" OR "angelman* syndrome" OR "prader-willi* syndrome" OR "dravet* syndrome" OR "marker chromosome 15" OR "isodicentric 15" OR "cri-du-chat syndrome" OR "5p deletion syndrome") | 15 537 |
| 2. | TI (child* OR kid* OR toddler* OR boy* OR girl* OR preshool* OR pre-shool* OR kindergarten* OR infant* OR newborn* OR new-born* OR neonat* OR baby* OR babies OR p?ediatric*) OR AB (child* OR kid* OR toddler* OR boy* OR girl* OR preshool* OR pre-shool* OR kindergarten* OR infant* OR newborn* OR new-born* OR neonat* OR baby* OR babies OR p?ediatric*) OR SU (child* OR kid* OR toddler* OR boy* OR girl* OR preshool* OR pre-shool* OR kindergarten* OR infant* OR newborn* OR new-born* OR neonat* OR baby* OR babies OR p?ediatric*) | 1 114 463 |
| Study types: systematic reviews and meta-analysis / randomized controlled trials | ||
| 3. | (TI (((systematic OR realist OR integrative OR “mixed method*” OR umbrella) N3 review) OR "meta analys*" OR metaanalys*) OR AB (((systematic OR realist OR integrative OR “mixed method*” OR umbrella) N3 review) OR "meta analys*" OR metaanalys*) OR SU (((systematic OR realist OR integrative OR “mixed method*” OR umbrella) N3 review) OR "meta analys*" OR metaanalys*)) OR (MR "Systematic Review" OR MR "meta analysis") | 128 099 |
| Combined sets: | ||
| 4. | 1 AND 2 | 8721 |
| Final result | ||
| 5. | 4 AND 3 | 113 |